Skip to main content
Erschienen in: International Urology and Nephrology 2/2014

01.02.2014 | Urology - Original Paper

Metabolic evaluation of patients with urinary system stone disease: a research of pediatric and adult patients

verfasst von: Ural Oğuz, Berkan Resorlu, Ali Unsal

Erschienen in: International Urology and Nephrology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the metabolic risk factors in children and adults with urinary system stone disease.

Materials and methods

Between September 2008 and February 2011, 257 patients who underwent 24-h urine analysis because of urinary system stone disease were included in the present study. Group I and II include only adult patients. The first-time stone formers were named as Group I (n = 106), and recurrent stone formers were named as Group II (n = 107). Group III was occurred by pediatric patients (n = 44). Control group includes 105 people was called as Group IV. This group was divided into two subgroups. Group IVa includes 70 adult people, and Group IVb includes 35 children. The metabolic evaluation results of patients and control groups were compared.

Results

Hypercalciuria (35.8, 44.9, and 47.7 % for Group I, II, and III, respectively) and hypocitraturia (42.5, 40.2, and 50 % for Group I, II, and III, respectively) were most common risk factors for stone formation. However, unlike the literature, we have seen that hypomagnesiuria is also an important risk factor in adults and children. Hypomagnesiuria was defined at 36.4 % in Group I, 29 % in Group II, and 56.8 % in Group III (p < 0.05 for each group). These three parameters were significantly different between patient and control groups.

Conclusions

Hypomagnesiuria, hypocitraturia, and hypercalciuria are the most important risk factors for stone formation in adults and pediatric patients.
Literatur
1.
Zurück zum Zitat Bandi G, Nakada SY, Penniston KL (2008) Practical approach to metabolic evaluation and treatment of the recurrent stone patient. WMJ 107:91–100PubMed Bandi G, Nakada SY, Penniston KL (2008) Practical approach to metabolic evaluation and treatment of the recurrent stone patient. WMJ 107:91–100PubMed
2.
Zurück zum Zitat Pearle MS, Lotan Y (2012) Urinary lithiasis: etiology, epidemiology and pathogenesis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology, 10th edn. Saunders Elsevier, Philadelphia, pp 1257–1410 Pearle MS, Lotan Y (2012) Urinary lithiasis: etiology, epidemiology and pathogenesis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds) Campbell-Walsh urology, 10th edn. Saunders Elsevier, Philadelphia, pp 1257–1410
3.
4.
Zurück zum Zitat Muslumanoglu AY, Binbay M, Yuruk E et al (2011) Updated epidemiologic study of urolithiasis in Turkey. I: changing characteristics of urolithiasis. Urol Res 39:309–314PubMedCrossRef Muslumanoglu AY, Binbay M, Yuruk E et al (2011) Updated epidemiologic study of urolithiasis in Turkey. I: changing characteristics of urolithiasis. Urol Res 39:309–314PubMedCrossRef
5.
Zurück zum Zitat Erbagci A, Erbagci AB, Yilmaz M et al (2003) Pediatric urolithiasis-evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133PubMedCrossRef Erbagci A, Erbagci AB, Yilmaz M et al (2003) Pediatric urolithiasis-evaluation of risk factors in 95 children. Scand J Urol Nephrol 37:129–133PubMedCrossRef
6.
Zurück zum Zitat Ljunghall S, Danielson BG (1984) A prospective study of renal stone recurrences. Br J Urol 56:122–124PubMedCrossRef Ljunghall S, Danielson BG (1984) A prospective study of renal stone recurrences. Br J Urol 56:122–124PubMedCrossRef
8.
Zurück zum Zitat Ertan P, Tekin G, Oger N et al (2011) Metabolic and demographic characteristics of children with urolithiasis in Western Turkey. Urol Res 39:105–110PubMedCrossRef Ertan P, Tekin G, Oger N et al (2011) Metabolic and demographic characteristics of children with urolithiasis in Western Turkey. Urol Res 39:105–110PubMedCrossRef
9.
Zurück zum Zitat Saita A, Bonaccorsi A, Motta M (2007) Stone composition: where do we stand? Urol Int 79:16–19PubMedCrossRef Saita A, Bonaccorsi A, Motta M (2007) Stone composition: where do we stand? Urol Int 79:16–19PubMedCrossRef
10.
Zurück zum Zitat Park S (2007) Medical management of urinary stone disease. Expert Opin Pharmacother 8:1117–1125PubMedCrossRef Park S (2007) Medical management of urinary stone disease. Expert Opin Pharmacother 8:1117–1125PubMedCrossRef
11.
Zurück zum Zitat Goyal M, Grossberg RI, O’Riordan MA et al (2009) Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr Neurol 40:289–294PubMedCrossRef Goyal M, Grossberg RI, O’Riordan MA et al (2009) Urolithiasis with topiramate in nonambulatory children and young adults. Pediatr Neurol 40:289–294PubMedCrossRef
12.
Zurück zum Zitat Rivers K, Shetty S, Menon M (2000) When and how to evaluate a patient with nephrolithiasis. Urol Clin North Am 27:203–213PubMedCrossRef Rivers K, Shetty S, Menon M (2000) When and how to evaluate a patient with nephrolithiasis. Urol Clin North Am 27:203–213PubMedCrossRef
13.
Zurück zum Zitat Amaro CR, Goldberg J, Amaro JL et al (2005) Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 31:29–33PubMedCrossRef Amaro CR, Goldberg J, Amaro JL et al (2005) Metabolic assessment in patients with urinary lithiasis. Int Braz J Urol 31:29–33PubMedCrossRef
14.
Zurück zum Zitat Hess B, Hasler-Strub U, Acherman D et al (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nepfrol Dial Transplant 12:1362–1368CrossRef Hess B, Hasler-Strub U, Acherman D et al (1997) Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nepfrol Dial Transplant 12:1362–1368CrossRef
15.
Zurück zum Zitat Spivacow FR, Negri AL, del Valle EE et al (2008) Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 23:1129–1133PubMedCrossRef Spivacow FR, Negri AL, del Valle EE et al (2008) Metabolic risk factors in children with kidney stone disease. Pediatr Nephrol 23:1129–1133PubMedCrossRef
16.
Zurück zum Zitat Serra A, Domingos F, Salgueiro C et al (2004) Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal. Acta Med Port 17:27–34PubMed Serra A, Domingos F, Salgueiro C et al (2004) Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal. Acta Med Port 17:27–34PubMed
17.
Zurück zum Zitat Tefekli A, Esen T, Ziylan O et al (2003) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 70:273–277PubMedCrossRef Tefekli A, Esen T, Ziylan O et al (2003) Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference? Urol Int 70:273–277PubMedCrossRef
18.
Zurück zum Zitat Spivacow FR, Negri AL, del Valle EE et al (2010) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475PubMedCrossRef Spivacow FR, Negri AL, del Valle EE et al (2010) Clinical and metabolic risk factor evaluation in young adults with kidney stones. Int Urol Nephrol 42:471–475PubMedCrossRef
19.
Zurück zum Zitat Alpay H, Ozen A, Gokce I et al (2009) Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 24:2203–2209PubMedCrossRef Alpay H, Ozen A, Gokce I et al (2009) Clinical and metabolic features of urolithiasis and microlithiasis in children. Pediatr Nephrol 24:2203–2209PubMedCrossRef
20.
Zurück zum Zitat Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin North Am 34:323–334PubMedCrossRef Park S, Pearle MS (2007) Pathophysiology and management of calcium stones. Urol Clin North Am 34:323–334PubMedCrossRef
21.
Zurück zum Zitat Glémain P, Prunet D (2006) Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients. Prog Urol 16:542–545PubMed Glémain P, Prunet D (2006) Identification of lithogenic risk factors by a simplified first-line laboratory assessment in urinary calculi patients. Prog Urol 16:542–545PubMed
22.
Zurück zum Zitat Sarica K (2006) Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 34:96–101PubMedCrossRef Sarica K (2006) Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment. Urol Res 34:96–101PubMedCrossRef
23.
Zurück zum Zitat Gürgöze MK, Sarı MY (2011) Results of medical treatment and metabolic risk factors in children with urolithiasis. Pediatr Nephrol 26:933–937PubMedCrossRef Gürgöze MK, Sarı MY (2011) Results of medical treatment and metabolic risk factors in children with urolithiasis. Pediatr Nephrol 26:933–937PubMedCrossRef
24.
Zurück zum Zitat Hosseini MM, Eshraghian A, Dehghanian I et al (2010) Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol 42:127–131PubMedCrossRef Hosseini MM, Eshraghian A, Dehghanian I et al (2010) Metabolic abnormalities in patients with nephrolithiasis: comparison of first-episode with recurrent cases in Southern Iran. Int Urol Nephrol 42:127–131PubMedCrossRef
25.
Zurück zum Zitat Dursun I, Poyrazoglu HM, Dusunsel R et al (2008) Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 40:3–9PubMedCrossRef Dursun I, Poyrazoglu HM, Dusunsel R et al (2008) Pediatric urolithiasis: an 8-year experience of single centre. Int Urol Nephrol 40:3–9PubMedCrossRef
26.
Zurück zum Zitat Stitchantrakul W, Kochakarn W, Ruangraksa C et al (2007) Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai 90:688–698PubMed Stitchantrakul W, Kochakarn W, Ruangraksa C et al (2007) Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai 90:688–698PubMed
27.
Zurück zum Zitat Lande MB, Varade W, Erkan E et al (2005) Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol 20:491–494PubMedCrossRef Lande MB, Varade W, Erkan E et al (2005) Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol 20:491–494PubMedCrossRef
28.
Zurück zum Zitat Battino BS, DeFOOR W, Coe F et al (2002) Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol 168:2568–2571PubMedCrossRef Battino BS, DeFOOR W, Coe F et al (2002) Metabolic evaluation of children with urolithiasis: are adult references for supersaturation appropriate? J Urol 168:2568–2571PubMedCrossRef
29.
Zurück zum Zitat Lancina Martín JA, Rodríguez-Rivera García J, Novás Castro S et al (2002) Metabolic risk factors in calcium urolithiasis according to gender and age of the patients. Actas Urol Esp 26:111–120PubMedCrossRef Lancina Martín JA, Rodríguez-Rivera García J, Novás Castro S et al (2002) Metabolic risk factors in calcium urolithiasis according to gender and age of the patients. Actas Urol Esp 26:111–120PubMedCrossRef
30.
Zurück zum Zitat Goldfarber David S (1999) Prevention of recurrent nephrolithiasis. Am Fam Physician 60:2269–2276 Goldfarber David S (1999) Prevention of recurrent nephrolithiasis. Am Fam Physician 60:2269–2276
31.
Zurück zum Zitat Pietrow PK, Pope JC 4th, Adams MC et al (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673PubMedCrossRef Pietrow PK, Pope JC 4th, Adams MC et al (2002) Clinical outcome of pediatric stone disease. J Urol 167:670–673PubMedCrossRef
Metadaten
Titel
Metabolic evaluation of patients with urinary system stone disease: a research of pediatric and adult patients
verfasst von
Ural Oğuz
Berkan Resorlu
Ali Unsal
Publikationsdatum
01.02.2014
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 2/2014
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-013-0539-3

Weitere Artikel der Ausgabe 2/2014

International Urology and Nephrology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.